173 filings
6-K
CNTG
Centogene NV
2 Apr 24
CENTOGENE Receives Nasdaq Non-Compliance Notice
4:30pm
6-K
CNTG
Centogene NV
19 Mar 24
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
6:30am
6-K
CNTG
Centogene NV
29 Feb 24
Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected
5:00pm
6-K
CNTG
Centogene NV
28 Feb 24
CENTOGENE Explores Strategic Alternatives
6:30am
6-K
CNTG
Centogene NV
28 Feb 24
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
6:30am
6-K
CNTG
Centogene NV
25 Jan 24
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
6:30am
6-K
CNTG
Centogene NV
24 Jan 24
CENTOGENE Receives French Research Tax Credit Accreditation
6:30am
6-K
CNTG
Centogene NV
23 Jan 24
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
6:36am
6-K
CNTG
Centogene NV
18 Jan 24
CENTOGENE Announces Preliminary Full Year 2023 Revenue
7:02am
6-K
CNTG
Centogene NV
19 Dec 23
CENTOGENE Announces Voting Results of Extraordinary General Meeting
7:10am
6-K
CNTG
Centogene NV
18 Dec 23
CENTOGENE Announces Changes in Supervisory Board
6:41am
6-K
CNTG
Centogene NV
13 Dec 23
Current report (foreign)
6:33am
6-K
CNTG
Centogene NV
1 Dec 23
Current report (foreign)
6:30am
6-K
CNTG
Centogene NV
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
6-K
CNTG
Centogene NV
3 Nov 23
Third Amendment to Loan and Security Agreement
4:30pm
6-K
CNTG
Centogene NV
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
6-K
CNTG
Centogene NV
10 Oct 23
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
6:30am
6-K
CNTG
Centogene NV
6 Oct 23
CENTOGENE Announces Changes in Supervisory Board
4:30pm
6-K
CNTG
Centogene NV
7 Sep 23
CENTOGENE Reports First Half 2023 Financial Results
5:00pm
6-K
CNTG
Centogene NV
1 Sep 23
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
8:00am